Delayed graft function in renal transplantation: Etiology, management and long-term significance

Journal of Urology

Volumn 155, Issue 6, 1996, Pages 1831-1840

  Shoskes, Daniel A ^b   Halloran, Philip F ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

immunology; kidney failure, acute; kidney transplantation; organ transplantation; reperfusion injury

Indexed keywords

21 AMINOSTEROID; AZATHIOPRINE; CALCIUM CHANNEL BLOCKING AGENT; COLLINS SOLUTION; CYCLOSPORIN; DILTIAZEM; DIURETIC AGENT; ENISOPROST; FELODIPINE; HLA ANTIGEN CLASS 1; LYMPHOCYTE ANTIBODY; NIFEDIPINE; OKT 3; PROSTACYCLIN; UNIVERSITY OF WISCONSIN SOLUTION; VERAPAMIL;

ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; CADAVER KIDNEY; CLINICAL TRIAL; CREATININE BLOOD LEVEL; GRAFT SURVIVAL; HUMAN; IMMUNE INJURY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY ISCHEMIA; KIDNEY PRESERVATION; KIDNEY TRANSPLANTATION; LONG TERM CARE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; TREATMENT OUTCOME;

EID: 0029978786     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)66023-3     Document Type: Review

References (141)

1. Almond, P. S., Matas, A. J. and Canafax, D. M.: Fixed-rate reimbursement fails to cover costs for patients with delayed graft function. Pharmacotherapy, 11: 126S, 1991.
2. Almond, P. S., Troppmann, C., Escobar, F., Frey, D. J. and Matas, A. J.: Economic impact of delayed graft function. Transplant. Proc., part 2, 23: 1304, 1991.
3. Rosenthal, J. T., Danovitch, G. M., Wilkinson, A. and Ettenger, R. B.: The high cost of delayed graft function in cadaveric renal transplantation. Transplantation, 51: 1115, 1991.
4. Shoskes, D. A., Churchill, B. M., McLorie, G. A. and Khoury, A.: The impact of ischemic and immunologic factors on early graft function in pediatric renal transplantation. Transplantation, 50: 877, 1990.
5. Weinberg, J. M.: The cell biology of ischemic renal injury. Kidney Int., 39: 476, 1991.
6. Toback, F. G.: Regeneration after acute tubular necrosis. Kidney Int., 41: 226, 1992.
7. Darby, J. M., Stein, K., Grenvik, A. and Stuart, S. A.: Approach to management of the heartbeating 'brain dead' organ donor. J.A.M.A., 261: 2222, 1989.
8. Starzl, T. E., Miller, C., Broznick, B. and Makowka, L.: An improved technique for multiple organ harvesting. Surg., Gynec. & Obst., 165: 343, 1987.
9. Wynen, R. M., Booster, M., Speatgens, C., Yin, M., van Hoof, J. P., de Boer, J. and Kootstra, G.: Long-term follow-up of transplanted non-heart-beating donor kidneys: preliminary results of a retrospective study. Transplant. Proc., part 2, 25: 1522, 1993.
10. Parmar, M. S., Kjellstrand, C. M., Solez, K. and Halloran, P. F.: Glomerular endothelial cell detachment in paired cadaver kidney transplants: evidence that some cadaver donors have pre-existing endothelial injury. Clin. Transplant., 8: 120, 1994.
11. Levine, R. L.: Ischemia: from acidosis to oxidation. FASEB J., 7: 1242, 1993.
12. Green, C. J., Gower, J. D., Healing, G., Cotterill, L. A., Fuller, B. J. and Simpkin, S.: The importance of iron, calcium and free radicals in reperfusion injury: an overview of studies in ischaemic rabbit kidneys. Free Radical Res. Commun., 7: 255, 1989.
13. Burke, T. J., Singh, H. and Schrier, R. W.: Calcium handling by renal tubules during oxygen deprivation injury to the kidney prior to reoxygenation. Cardiovasc. Drugs Ther., 4: 1319, 1990.
14. McCord, J. M.: Oxygen-derived free radicals in postischemic tissue injury. New Engl. J. Med., 312: 159, 1985.
15. Granger, D. N.: Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Amer. J. Physiol., part 2, 255: H1269, 1988.
16. Hochachka, P. W.: Defense strategies against hypoxia and hypothermia. Science, 231: 234, 1986.
17. Klausner, J. M., Paterson, I. S., Kobzik, L., Rodzen, C., Valeri, C. R., Shepro, D. and Hechtman, H. B.: Vasodilating prostaglandins attenuate ischemic renal injury only if thromboxane is inhibited. Ann. Surg., 209: 219, 1989.
18. Chintala, M. S., Chiu, P. J., Vemulapalli, S., Watkins, R. W. and Sybertz, E. J.: Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats. Naunyn Schmiedebergs Arch. Pharmacol., 348: 305, 1993.
19. Emami, A., Schwartz, J. H. and Borkan, S. C.: Transient ischemia or heat stress induces a cytoprotectant protein in rat kidney. Amer. J. Physiol., part 2, 260: F479, 1991.
20. Bonventre, J. V., Sukhatme, V. P., Bamberger, M., Ouellette, A. J. and Brown, D.: Localization of the protein product of the immediate early growth response gene, Egr-1, in the kidney after ischemia and reperfusion. Cell Regulation, 2: 251, 1991.
21. Paller, M. S.: Free radical-mediated postischemic injury in renal transplantation. Renal Failure, 14: 257, 1992.
22. Deneke, S. M. and Fanburg, B. L.: Regulation of cellular glutathione. Amer. J. Physiol., 257: L163, 1989.
23. Weinberg, J. M.: Glutathione and glycine in acute renal failure. Renal Failure, 14: 311, 1992.
24. Hall, T. S., Breda, M. A., Baumgartner, W. A., Borkon, A. M., Brawn, J., Hutchins, G. M. and Reitz, B. A.: The role of leukocyte depletion in reducing injury to the lung after hypothermic ischemia. J. Curr. Surg., 44: 137, 1987.
25. Welbourn, C. R., Goldman, G., Paterson, I. S., Valeri, C. R., Shepro, D. and Hechtman, H. B.: Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Brit. J. Surg., 78: 651, 1991.
26. Conger, J. D., Robinette, J. B. and Kelleher, S. P.: Nephron heterogeneity in ischemic acute renal failure. Kidney Int., 26: 422, 1984.
27. Oken, D. E.: Acute renal failure (vasomotor nephropathy): micropuncture studies of the pathogenetic mechanisms. Ann. Rev. Med., 26: 307, 1975.
28. Hollenberg, N. K., Retik, A. B., Rosen, S. M., Murray, J. E. and Merrill, J. P.: The role of vasoconstriction in the ischemia of renal allograft rejection. Transplantation, 6: 59, 1968.
29. Myers, B. D., Miller, D. C., Mehigan, J. T., Olcott, C. O., IV, Golbetz, H., Robertson, C. R., Derby, G., Spencer, R. and Friedman, S.: Nature of the renal injury following total renal ischemia in man. J. Clin. Invest., 73: 329, 1984.
30. Conger, J. D., Falk, S. A., Yuan, B. H. and Schrier, R. W.: Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure. Kidney Int., 35: 1126, 1989.
31. Tanner, G. A., Sloan, K. L. and Sophasan, S.: Effects of renal artery occlusion on kidney function in the rat. Kidney Int., 4: 377, 1973.
32. Finn, W. F., Hak, L. J. and Grossman, S. H.: Protective effect of prostacyclin on postischemic acute renal failure in the rat. Kidney Int., 32: 479, 1987.
33. Bhardwaj, R. and Moore, P. K.: The effect of arginine and nitric oxide on resistance blood vessels of the perfused rat kidney. Brit. J. Pharmacol., 97: 739, 1989.
34. Brezis, M., Heyman, S. N., Dinour, D., Epstein, F. H. and Rosen, S.: Role of nitric oxide in renal medullary oxygenation. Studies in isolated and intact rat kidneys. J. Clin. Invest., 88: 390, 1991.
35. Lieberthal, W., Wolf, E. F., Rennke, H. G., Valeri, C. R. and Levinsky, N. G.: Renal ischemia and reperfusion impair endothelium-dependent vascular relaxation. Amer. J. Physiol., part 2, 256: F894, 1989.
36. Safirstein, R., Zelent, A. Z. and Price, P. M.: Reduced renal prepro-epidermal growth factor mRNA and decreased EGF excretion in ARF. Kidney Int., 36: 810, 1989.
37. Safirstein, R., Price, P. M., Saggi, S. J. and Harris, R. C.: Changes in gene expression after temporary renal ischemia. Kidney Int., 37: 1515, 1990.
38. Humes, D., Cieslinski, D., Coimbra, T., Messana, J. and Galvao, C.: Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic ARF. J. Clin. Invest., 84: 1757, 1989.
39. Norman, J., Tasu, Y., Bacay, A. and Fine, L.: Epidermal growth factor accelerates functional recovery from ischaemic acute tubular necrosis in the rat: role of the EGF receptor. Clin. Sci., 78: 445, 1990.
40. Killion, D., Canfield, C., Norman, J. and Rosenthal, J. T.: Exogenous epidermal growth factor fails to accelerate functional recovery in the autotransplanted ischemic pig kidney. J. Urol., 150: 1551, 1993.
41. Ploeg, R. J., van Bockel, J. H., Langendyk, P. T., Groenewegen, M., van der Woude, F. J., Persijn, G. G., Thorogood, J. and Hermans, J.: Effect of preservation solution on results of cadaveric kidney transplantation. The European Multicentre Study Group. Lancet, 340: 129, 1992.
42. Wijnen, R. M., Booster, M. H., Stubenitsky, B. M., de Boer, J., Heineman, E. and Kootstra, G.: Outcome of transplantation of non-heart-beating donor kidneys. Lancet, 345: 1067, 1995.
43. Rabanal, J. M., Teja, J. L., Quesada, A. and Cotorruelo, J.: Does diabetes insipidus in brain dead organ donors protect acute tubular necrosis in renal grafts? Transplant. Proc., 25: 3143, 1993.
44. Thoren, O.: Ischemia time and time for onset of graft function after cadaveric kidney transplantation. Scand. J. Urol. Nephrol., 38: 33, 1976.
45. Mertes, P. M., el Abassi, K., Jaboin, Y., Burtin, P., Pinelli, G., Carteaux, J. P., Burlet, C., Boulange, M. and Villemot, J. P.: Changes in hemodynamic and metabolic parameters following induced brain death in the pig. Transplantation, 58: 414, 1994.
46. Ferguson, C. J., Hillis, A. N., Williams, J. D., Griffin, P. J. and Salaman, J. R.: Calcium-channel blockers and other factors influencing delayed function in renal allografts. Nephrol. Dialysis Transplant., 5: 816, 1990.
47. Canafax, D. M., Torres, A., Fryd, D. S., Heil, J. E., Strand, M. H., Ascher, N. L., Payne, W. D., Sutherland, D. E., Simmons, R. L. and Najarian, J. S.: The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine. Transplantation, 41: 177, 1986.
48. Kahan, B. D., Mickey, R., Flechner, S. M., Lorber, M. I., Wideman, C. A., Kerman, R. H., Terasaki, P. and Van Buren, C. T.: Multivariate analysis of risk factors impacting on immediate and eventual cadaver allograft survival in cyclosporine-treated recipients. Transplantation, 43: 65, 1987.
49. Halloran, P. and Aprile, M.: Factors influencing early renal function in cadaver kidney transplants. A case-control study. Transplantation, 45: 122, 1988.
50. Merkus, J. W., Hoitsma, A. J. and Koene, R. A.: Detrimental effect of acute renal failure on the survival of renal allografts: influence of total ischaemia time and anastomosis time. Nephrol. Dialysis Transplant., 6: 881, 1991.
51. Halloran, P. F. and Shoskes, D. A.: Early transplant nonfunction - influence on ultimate graft survival and function. In: Acute Renal Failure: Diagnosis, Treatment and Prevention. Edited by K. Solez and L. C. Racusen. New York: Marcel Dekkar, Inc., p. 387, 1991.
52. Belzer, F. O. and Southard, J. H.: Principles of solid-organ preservation by cold storage. Transplantation, 45: 673, 1988.
53. Halloran, P. and Aprile, M.: A randomized prospective trial of cold storage versus pulsatile perfusion for cadaver kidney preservation. Transplantation, 43: 827, 1987.
54. Merion, R. M., Oh, H. K., Port, F. K., Toledo-Pereyra, L. H. and Turcotte, J. G.: A prospective controlled trial of cold-storage versus machine-perfusion preservation in cadaveric renal transplantation. Transplantation, 50: 230, 1990.
55. Tesi, J., Elkhammas, E. A., Davies, E. A., Henry, M. L. and Ferguson, R. M.: Pulsatile kidney perfusion for preservation and evaluation: use of high-risk kidney donors to expand the donor pool. Transplant. Proc., 25: 3099, 1993.
56. Halloran, P. F., Wadgymar, A., Ritchie, S., Falk, J., Solez, K. and Srinivasa, N. S.: The significance of the anti-class I antibody response. 1. Clinical and pathologic features of anti-class I-mediated rejection. Transplantation, 49: 85, 1990.
57. Dawidson, I. J., Sandor, Z. F., Coorpender, L., Palmer, B., Peters, P., Lu, C., Sagalowsky, A., Risser, R. and Willms, C.: Intraoperative albumin administration affects the outcome of cadaver renal transplantation. Transplantation, 53: 774, 1992.
58. Dawidson, I. J. and Ar'Rajab, A.: Perioperative fluid and drug therapy during cadaver kidney transplantation. Clin. Transplants, p. 267, 1992.
59. Tiggeler, R. G., Berden, J. H., Hoitsma, A. J. and Koene, R. A.: Prevention of acute tubular necrosis in cadaveric kidney transplantation by the combined use of mannitol and moderate hydration. Ann. Surg., 201: 246, 1985.
60. Lauzurica, R., Teixidó, J., Serra, A., Torguet, P., Bonet, J., Bonal, J., Borrás, M., Romero, R. and Caralps, A.: Hydration and mannitol reduce the need for dialysis in cadaveric kidney transplant recipients treated with CyA. Transplant. Proc., 24: 46, 1992.
61. Lachance, S. L. and Barry, J. M.: Effect of furosemide on dialysis requirement following cadaveric kidney transplantation. J. Urol., 133: 950, 1985.
62. Neumayer, H. H., Kunzendorf, U. and Schreiber, M.: Protective effects of calcium antagonists in human renal transplantation. Kidney Int., suppl., 36: S87, 1992.
63. Suthanthiran, M., Haschemeyer, R. H., Riggio, R. R., Adubor, C., Friedman, G. S., Cheigh, J. S., Wang, J. C., Fotino, M., Stubenbord, W. T. and Saal, S. D.: Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. A potential strategy to avoid antibody induction protocols. Transplantation, 55: 1008, 1993.
64. Nyberg, G., Haljamäe, U., Herlitz, H., Nordén, G. and Blohmé, I.: Early renal graft function in recipients treated with the calcium channel blocker felodipine. Scand. J. Urol. Nephrol., 28: 17, 1994.
65. Pollak, R., Andrisevic, J. H., Maddux, M. S., Gruber, S. A. and Palier, M. S.: A randomized double-blind trial of the use of human recombinant superoxide dismutase in renal transplantation. Transplantation, 55: 57, 1993.
66. Land, W., Schneeberger, H., Schleibner, S., Illner, W. D., Abendroth, D., Rutili, G., Arfors, K. E. and Messmer, K.: The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation, 57: 211, 1994.
67. Forth, H. J., Rebmann, U., Heynemann, H., Schabel, J., Pauer, H. D., Mehlhorn, G., Scharf, R. and Mest, H. J.: The improvement of the tolerance of the kidney for ischemia with the prostacyclin analog iloprost. Z. Exp. Chir. Transplant. Kunstliche Organe, 23: 79, 1990.
68. Adams, M. B.: Enisoprost in renal transplantation. The Enisoprost Renal Transplant Study Group. Transplantation, 53: 338, 1992.
69. Gianello, P., Squifflet, J. P., Carlier, M., Lambotte, L., Ketelslegers, J. M. and Alexandre, G. P.: Atrial natriuretic factor: a protective role after acute renal ischemia? Is there room for it in kidney transplantation? Transplant. Int., 3: 41, 1990.
70. Lewis, R., Katz, S., Van Buren, C., Kerman, R. and Kahan, B.: Mechanisms and amelioration of acute renal allograft failure in the cyclosporine era. Renal Failure, 14: 267, 1992.
71. Stanley, J. J., Goldblum, J. R., Frank, T. S., Zelenock, G. B. and D'Alecy, L. G.: Attenuation of renal reperfusion injury in rats by the 21-aminosteroid U74006F. J. Vasc. Surg., 17: 685, 1993.
72. Jordan, M. L., Cook, G. T. and Cardella, C. J.: Ten years of experience with vascular complications in renal transplantation. J. Urol., 128: 689, 1982.
73. Shoskes, D. A., Hanbury, D., Cranston, D. and Morris, P. J.: Urological complications in 1,000 consecutive renal transplant recipients. J. Urol., 153: 18, 1995.
74. Smith, T. P., Hunter, D. W., Letourneau, J. G., Cragg, A. H., Darcy, M. D., Castaneda-Zuniga, W. R. and Amplatz, K.: Urine leaks after renal transplantation: value of percutaneous pyelography and drainage for diagnosis and treatment. AJR, 151: 511, 1988.
75. Cullmann, H. J. and Prosinger, M.: Necrosis of the allograft ureter - evaluation of different examination methods in early diagnosis. Urol. Int., 45: 164, 1990.
76. Rigsby, C. M., Burns, P. N., Weltin, G. G., Chen, B., Bia, M. and Taylor, K. J.: Doppler signal quantitation in renal allografts: comparison in normal and rejecting transplants, with pathologic correlation. Radiology, 162: 39, 1987.
77. Felling, M. and Dubbins, P. A.: Doppler and color Doppler imaging in acute transplant failure. J. Clin. Ultrasound, 20: 507, 1992.
78. Delaney, V., Ling, B. N., Campbell, W. G., Bourke, J. E., Fekete, P. S., O'Brien, D. P., III, Taylor, A. T. and Whelchel, J. D.: Comparison of fine-needle aspiration biopsy, Doppler ultrasound, and radionuclide scintigraphy in the diagnosis of acute allograft dysfunction in renal transplant recipients: sensitivity, specificity, and cost analysis. Nephron, 63: 263, 1993.
79. Shanahan, W. S., Klingensmith, W. C., III and Weil, R., III: 99mTc-DTPA renal studies for acute tubular necrosis: specificity of dissociation between perfusion and clearance. AJR, 136: 249, 1981.
80. Solez, K., McGraw, D. J., Beschorner, W. E. and Burdick, J. F.: Pathology of "acute tubular necrosis" and acute rejection: observations on early systematic renal transplant biopsies. In: Kidney Transplant Rejection. Diagnosis and Treatment. Edited by G. M. Williams, J. F. Burdick and K. Solez. New York: Marcel Dekker, Inc., chapt. 10, pp. 207-224, 1986.
81. Kadieva, V. S., Friedman, L., Margolius, L. P., Jackson, S. A. and Morrell, D. F.: The effect of dopamine on graft function in patients undergoing renal transplantation. Anesth. Anal., 76: 362, 1993.
82. Novick, A. C., Hwei, H. H., Steinmuller, D., Streem, S. B., Cunningham, R. J., Steinhilber, D., Goormastic, M. and Buszta, C.: Detrimental effect of cyclosporine on initial function of cadaver renal allografts following extended preservation. Results of a randomized prospective study. Transplantation, 42: 154, 1986.
83. Howard, R. J., Pfaff, W. W., Brunson, M. E., Ramos, E. L., Peterson, J. C., Croker, B. P., Scornik, J. C., Parris, C. J. and Fennell, R. S.: Delayed graft function is associated with an increased incidence of occult rejection and results in poorer graft survival. Transplant. Proc., part 2, 25: 884, 1993.
84. Whittaker, J. R., Veith, F. J. and Soberman, R.: The fate of the renal transplant with delayed function. Surg., Gynec. & Obst., 136: 919, 1973.
85. Williams, G. M., White, H. J. and Hume, D. M.: Factors influencing the long term functional success rate of human renal allografts. Transplantation, suppl., 5: 837, 1967.
86. Cho, S. I., Olsson, C. A., Bradley, J. W. and Nasbeth, D. C.: Regional program for kidney preservation and transplantation in New England. Amer. J. Surg., 131: 428, 1976.
87. Opelz, G., Sasaki, N. and Terasaki, P. I.: Prediction of long-term kidney transplant survival rates by monitoring early graft function and clinical grades. Transplantation, 25: 212, 1978.
88. McDonald, J. C., Vaughn, W., Filo, R. S., Picon, G. M., Niblack, G., Spees, E. K. and Williams, G. M.: Cadaver donor renal transplantation by centers of the Southeastern Organ Procurement Foundation. Ann. Surg., 193: 1, 1981.
89. Sanfilippo, F., Vaughn, W. K., Spees, E. K. and Lucas, B. A.: The detrimental effects of delayed graft function in cadaver donor renal transplantation. Transplantation, 38: 643, 1984.
90. Mendez-Picon, G., Posner, M. P., McGeorge, M. B., Baquero, A., Goldman, M. H., Monahanakumar, T. and Lee, H. M.: The effect of delayed function on long term survival of renal allografts. Surg., Gynec. & Obst., 161: 351, 1985.
91. Barry, J. M., Norman, D., Fuchs, E. F., Fischer, S. and Bennett, W. M.: Influence of acute tubular necrosis on first cadaver kidney transplant function. J. Urol., 132: 234, 1984.
92. Rocher, L. L., Landis, C., Dafoe, D. C., Keyserling, C., Swartz, R. D. and Campbell, D. A., Jr.: The long-term deleterious effect of delayed graft function in cyclosporine-treated renal allograft recipients. Transplant. Proc., part 3, 19: 2093, 1987.
93. Belitsky, P., MacDonald, A. S., Gajewski, J., Boudreau, J., Bitter-Suermann, H. and Cohen, A.: Significance of delayed function in cyclosporine-treated cadaver kidney transplants. Transplant. Proc., 19: 2096, 1987.
94. Sumrani, N. B., Miles, A. M., Daskalakis, P., Hong, J. H., Markell, M. S., Friedman, E. A. and Sommer, B. G.: Intermediate-term outcome of renal retransplants in the cyclosporine era. ASAIO J., 39: 47, 1993.
95. Bauma, W. D., Tang, I. Y., Maddux, M. S., Veremis, S. A., Pollak, R. and Mozes, M. F.: Delayed graft function following cadaver renal transplantation in the cyclosporine era: analysis of acute rejection and graft survival. Transplant. Proc., part 2, 21: 1276, 1989.
96. Halloran, P. F., Aprile, M. A., Farewell, V., Ludwin, D., Smith, E. K., Tsai, S. Y., Bear, R. A., Cole, E. H., Fenton, S. S. and Cattran, D. C.: Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine. Transplantation, 46: 223, 1988.
97. Churchill, B. M., McLorie, G. A., Williot, P. and Merguerian, P. A.: Influence of early function on long-term pediatric cadaveric renal allograft survival. J. Urol., 143: 326, 1990.
98. Cecka, J. M., Cho, Y. W. and Terasaki, P. I.: Analyses of the UNOS Scientific Renal Transplant Registry at three years - early events affecting transplant success. Transplantation, 53: 59, 1992.
99. Kjellstrand, C. M., Casali, R. E., Simmons, R. L., Shideman, J. R., Buselmeier, T. J. and Najarian, J. S.: Etiology and prognosis in acute post-transplant renal failure. Amer. J. Med., 61: 190, 1976.
100. Brophy, D., Najarian, J. S. and Kjellstrand, G. M.: Acute tubular necrosis after renal transplantation. Transplantation, 29: 245, 1980.
101. Heil, J., Sutherland, E. R., Fryd, D. S., Ascher, N. L., Simmons, R. L. and Najarian, J. S.: Acute tubular necrosis of cadaver renal allografts does not correlate with organ sharing or preservation time but portends a poorer prognosis for long-term graft survival. Transplant. Proc., 16: 270, 1984.
102. Cacciarelli, T., Sumrani, N., Delaney, V., Hong, J. H., DiBenedetto, A. and Sommer, B. G.: The influence of delayed renal allograft function on long-term outcome in the cyclosporine era. Clin. Nephrol., 39: 335, 1993.
103. Yokoyama, I., Uchica, K., Kobayashi, T., Tominaga, Y., Orihara, A. and Takagi, H.: Effect of prolonged delayed graft function on long-term graft outcome in cadaveric kidney transplantation. Clin. Transplant., 8: 101, 1994.
104. Sanfilippo, F., Vaughn, W. K., LeFor, W. N. and Specs, E. K.: Multivariate analysis of risk factors in cadaver donor kidney transplantation. Transplantation, 42: 28, 1986.
105. Paramasivan, O. N., Griffin, P. J., Ross, W. B. and Salaman, J. R.: The effect of acute tubular necrosis on cyclosporine-treated kidney transplants. Transplant. Proc., part 3, 19: 2085, 1987.
106. McMullin, N. D., Koffman, C. G., Rigdon, S. P., Haycock, G., Chantier, C. and Bewick, M.: The negative influence of delayed renal allograft function on longer-term graft survival in a pediatric population. J. Ped. Surg., 29: 66, 1994.
107. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years. The Canadian Multicentre Transplant Study Group. New Engl. J. Med., 314: 1219, 1986.
108. Lim, E. C. and Terasaki, P. I.: Early graft function. Clin. Transplants, pp. 401-407, 1991.
109. Cecka, J. M. and Terasaki, P. I.: The UNOS Scientific Renal Transplant Registry - 1990. Clin. Transplants, pp. 1-10, 1990.
110. Najarian, J. S., Gillingham, K. J., Sutherland, D. E., Reinsmoen, N. L., Payne, W. D. and Matas, A. J.: The impact of the quality of initial graft function on cadaver kidney transplants. Transplantation, 57: 812, 1994.
111. Halloran, P. F., Schlaut, J., Solez, K. and Srinivasa, N. S.: The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation, 53: 550, 1992.
112. Gulanikar, A. C., MacDonald, A. S., Sungurtekin, U. and Belitsky, P.: The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaver kidney transplants. Transplantation, 53: 323, 1992.
113. Ferguson, R.: Acute rejection episodes - best predictor of long-term primary cadaveric renal transplant survival. Clin. Transplant., part 2, 8: 328, 1994.
114. Nicholson, M. L., Horsburgh, T., Edwards, C. M., Morgan, J. D. T., Veitch, P. S. and Bell, P. R. F.: Relative influence of delayed graft function and acute rejection renal transplant survival. Abstracts of the British Transplantation Society, p. 41, 1994.
115. Orosz, C. G.: Endothelial activation and chronic allograft rejection. Clin. Transplant., part 2, 8: 299, 1994.
116. Shoskes, D. A. and Wood, K. J.: Indirect presentation of MHC antigens in transplantation. Immunol. Today, 15: 32, 1994.
117. Halloran, P. F. and Madrenas, J.: Regulation of MHC transcription. Transplantation, 50: 725, 1990.
118. Milton, A. D. and Fabre, J. W.: Massive induction of donor-type class I and class II histocompatibility complex antigens in rejecting cardiac allografts in the rat. J. Exp. Med., 161: 98, 1985.
119. Fuggle, S. V., McWhinnie, D. L. and Morris, P. J.: Precise specificity of induced tubular HLA-class II antigens in renal allografts. Transplantation, 44: 214, 1987.
120. Bekkhoucha, F., Naquet, P., Pierres, A., Marchetto, S. and Pierres, M.: Efficiency of antigen presentation to T cell clones by (B cell × B cell lymphoma) hybridomas correlates quantitatively with cell surface ia antigen expression. Eur. J. Immunol., 14: 807, 1984.
121. Shoskes, D. A., Parfrey, N. A. and Halloran, P. F.: Increased major histocompatibility complex antigen expression in unilateral ischemic acute tubular necrosis in the mouse. Transplantation, 49: 201, 1990.
122. Shoskes, D. A. and Halloran, P. F.: Ischemic injury induces altered MHC gene expression in kidney, by an interferon-gamma-dependent pathway. Transplant. Proc., 23: 599, 1991.
123. Goes, N., Urmson, J., Ramassar, V. and Halloran, P. F.: Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation, 59: 565, 1995.
124. Solez, K., McGraw, D. J., Beschorner, W. E., Kone, B. C., Racusen, L. C., Whelton, A. and Burdick, J. F.: Reflections on use of the renal biopsy as the "gold standard" in distinguishing transplant rejection from cyclosporine nephrotoxicity. Transplant. Proc., suppl. 1, 17: 123, 1985.
125. Shackleton, C. R., Ettinger, S. L., McLoughlin, M. G., Scudamore, C. H., Miller, R. R. and Keown, P. A.: Effect of recovery from ischemic injury on class I and class II MHC antigen expression. Transplantation, 49: 641, 1990.
126. Compeau, C. G., Ma, J., DeCampos, K. N., Waddell, T. K., Brisseau, G. F., Slutsky, A. S. and Rotstein, O. D.: In situ ischemia and hypoxia enhance alveolar macrophage tissue factor expression. Amer. J. Respiratory Cell Molec. Biol., 11; 446, 1994.
127. Wakabayashi, H., Miyauchi, A., Karasawa, Y., Hamamoto, I., Maeba, T. and Tanaka, S.: Effect of warm ischemia and reperfusion injury on inducing major histocompatibility complex antigens on hepatocytes and nonparenchymal cells in the rat liver. Transplant. Proc., 25: 3205, 1993.
128. Goes, N., Urmson, J., Ramassar, V., Vincent, D. and Halloran, P. F.: Effect of rh insulin like growth factor I on the inflammatory response to acute renal injury. J. Amer. Soc. Nephrol., in press.
129. Ibrahim, M. A., Chain, B. M. and Katz, D. R.: The injured cell: the role of the dendritic cell system as a sentinel receptor pathway. Immunol. Today, 16: 181, 1995.
130. Shoskes, D. A., Hodge, E. E., Goormastic, M., Goldfarb, D. A. and Novick, A. C.: HLA matching determines susceptibility to harmful effects of delayed graft function in renal transplant recipients. Transplant. Proc., 27: 1068, 1995.
131. Solez, K.: International standardization of criteria for histologic diagnosis of chronic rejection in renal allografts. Clin. Transplant., part 2, 8: 345, 1994.
132. Tullius, S. G., Hancock, W. W., Heemann, U., Azuma, H. and Tilney, N. L.: Reversibility of chronic renal allograft rejection. Critical effect of time after transplantation suggests both host immune dependent and independent phases of progressive injury. Transplantation, 58: 93, 1994.
133. Yilmaz, S., Paavonen, T. and Häyry, P.: Chronic rejection of rat renal allografts. II. The impact of prolonged ischemia time on transplant histology. Transplantation, 53: 823, 1992.
134. Clinton, S. K. and Libby, P.: Cytokines and growth factors in atherogenesis. Arch. Path. Lab. Med., 116: 1292, 1992.
135. Yamamoto, T., Noble, N. A., Miller, D. E. and Border, W. A.: Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int., 45: 916, 1994.
136. Hostetter, T. H., Olson, J. L., Rennke, H. G., Venkatachalam, M. A. and Brenner, B. M.: Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Amer. J. Physiol., 241: F85, 1981.
137. Novick, A. C., Gephardt, G., Guz, B., Steinmuller, D. and Tubbs, R. R.: Long-term follow-up after partial removal of a solitary kidney. New Engl. J. Med., 325: 1058, 1991.
138. Brenner, B. M., Cohen, R. A. and Milford, E. L.: In renal transplantation, one size may not fit all. J. Amer. Soc. Nephrol., 3: 162, 1992.
139. Brenner, B. M. and Milford, E. L.: Nephron underdosing: a programmed cause of chronic renal allograft failure. Amer. J. Kidney Dis., suppl. 2, 21: 66, 1993.
140. Barrientos, A., Portolés, J., Herrero, J. A., Torralbo, A., Prats, D., Gutierrez-Millet, V. and Blanco, J.: Glomerular hyperfiltration as a nonimmunologic mechanism of progression of chronic renal rejection. Transplantation, 57: 753, 1994.
141. Gaston, R. S., Hudson, S. L., Julian, B. A., Laskow, D. A., Deierhoi, M. H., Sanders, C. E., Phillips, M. G., Diethelm, A. G. and Curtis, J. J.: Impact of donor/recipient size matching on outcomes in renal transplantation. Transplantation, 61: 383, 1996.